IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-28450-1.html
   My bibliography  Save this article

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

Author

Listed:
  • Svenja Weiss

    (Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai)

  • Vincenza Itri

    (Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai)

  • Ruimin Pan

    (New York University School of Medicine)

  • Xunqing Jiang

    (New York University School of Medicine)

  • Christina C. Luo

    (New York University School of Medicine)

  • Lynn Morris

    (National Institute for Communicable Diseases, National Health Laboratory Service
    MRC Antibody Research Unit, University of the Witwatersrand, Johannesburg and Center for the AIDS Program of Research in South Africa)

  • Delphine C. Malherbe

    (Oregon National Primate Research Center, Oregon Health and Science University
    University of Texas Medical Branch, Department of Pathology, Galveston National Laboratory)

  • Philip Barnette

    (Oregon National Primate Research Center, Oregon Health and Science University)

  • Jeff Alexander

    (PaxVax Corporation
    JL Alexander Research and Development Consulting LLC)

  • Xiang-Peng Kong

    (New York University School of Medicine)

  • Nancy L. Haigwood

    (Oregon National Primate Research Center, Oregon Health and Science University)

  • Ann J. Hessell

    (Oregon National Primate Research Center, Oregon Health and Science University)

  • Ralf Duerr

    (New York University School of Medicine)

  • Susan Zolla-Pazner

    (Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine)

Abstract

V2p and V2i antibodies (Abs) that are specific for epitopes in the V1V2 region of the HIV gp120 envelope (Env) do not effectively neutralize HIV but mediate Fc-dependent anti-viral activities that have been correlated with protection from, or control of HIV, SIV and SHIV infections. Here, we describe a novel molecular toolbox that allows the discrimination of antigenically and functionally distinct polyclonal V2 Ab responses. We identify different patterns of V2 Ab induction by SHIV infection and three separate vaccine regimens that aid in fine-tuning an optimized immunization protocol for inducing V2p and V2i Abs. We observe no, or weak and sporadic V2p and V2i Abs in non-vaccinated SHIV-infected NHPs, but strong V2p and/or V2i Ab responses after immunization with a V2-targeting vaccine protocol. The V2-focused vaccination is superior to both natural infection and to immunization with whole Env constructs for inducing functional V2p- and V2i-specific responses. Strikingly, levels of V2-directed Abs correlate inversely with Abs specific for peptides of V3 and C5. These data demonstrate that a V1V2-targeting vaccine has advantages over the imprecise targeting of SIV/SHIV infections and of whole Env-based immunization regimens for inducing a more focused functional V2p- and V2i-specific Ab response.

Suggested Citation

  • Svenja Weiss & Vincenza Itri & Ruimin Pan & Xunqing Jiang & Christina C. Luo & Lynn Morris & Delphine C. Malherbe & Philip Barnette & Jeff Alexander & Xiang-Peng Kong & Nancy L. Haigwood & Ann J. Hess, 2022. "Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28450-1
    DOI: 10.1038/s41467-022-28450-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-28450-1
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-28450-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Nicole A. Doria-Rose & Chaim A. Schramm & Jason Gorman & Penny L. Moore & Jinal N. Bhiman & Brandon J. DeKosky & Michael J. Ernandes & Ivelin S. Georgiev & Helen J. Kim & Marie Pancera & Ryan P. Staup, 2014. "Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies," Nature, Nature, vol. 509(7498), pages 55-62, May.
    2. Mario Roederer & Brandon F. Keele & Stephen D. Schmidt & Rosemarie D. Mason & Hugh C. Welles & Will Fischer & Celia Labranche & Kathryn E. Foulds & Mark K. Louder & Zhi-Yong Yang & John-Paul M. Todd &, 2014. "Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV," Nature, Nature, vol. 505(7484), pages 502-508, January.
    3. Jason S. McLellan & Marie Pancera & Chris Carrico & Jason Gorman & Jean-Philippe Julien & Reza Khayat & Robert Louder & Robert Pejchal & Mallika Sastry & Kaifan Dai & Sijy O’Dell & Nikita Patel & Syed, 2011. "Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9," Nature, Nature, vol. 480(7377), pages 336-343, December.
    4. Morgane Rolland & Paul T. Edlefsen & Brendan B. Larsen & Sodsai Tovanabutra & Eric Sanders-Buell & Tomer Hertz & Allan C. deCamp & Chris Carrico & Sergey Menis & Craig A. Magaret & Hasan Ahmed & Micha, 2012. "Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2," Nature, Nature, vol. 490(7420), pages 417-420, October.
    5. Dan H. Barouch & Jinyan Liu & Hualin Li & Lori F. Maxfield & Peter Abbink & Diana M. Lynch & M. Justin Iampietro & Adam SanMiguel & Michael S. Seaman & Guido Ferrari & Donald N. Forthal & Ilnour Ourma, 2012. "Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys," Nature, Nature, vol. 482(7383), pages 89-93, February.
    6. Marie Pancera & Tongqing Zhou & Aliaksandr Druz & Ivelin S. Georgiev & Cinque Soto & Jason Gorman & Jinghe Huang & Priyamvada Acharya & Gwo-Yu Chuang & Gilad Ofek & Guillaume B. E. Stewart-Jones & Jon, 2014. "Structure and immune recognition of trimeric pre-fusion HIV-1 Env," Nature, Nature, vol. 514(7523), pages 455-461, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jeffy G. Mattathil & Asisa Volz & Olusegun O. Onabajo & Sean Maynard & Sandra L. Bixler & Xiaoying X. Shen & Diego Vargas-Inchaustegui & Marjorie Robert-Guroff & Celia Lebranche & Georgia Tomaras & Da, 2023. "Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251," Nature Communications, Nature, vol. 14(1), pages 1-15, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fangzhu Zhao & Zachary T. Berndsen & Nuria Pedreño-Lopez & Alison Burns & Joel D. Allen & Shawn Barman & Wen-Hsin Lee & Srirupa Chakraborty & Sandrasegaram Gnanakaran & Leigh M. Sewall & Gabriel Ozoro, 2022. "Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Kun-Wei Chan & Christina C. Luo & Hong Lu & Xueling Wu & Xiang-Peng Kong, 2021. "A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    3. Jason Gorman & Crystal Sao-Fong Cheung & Zhijian Duan & Li Ou & Maple Wang & Xuejun Chen & Cheng Cheng & Andrea Biju & Yaping Sun & Pengfei Wang & Yongping Yang & Baoshan Zhang & Jeffrey C. Boyington , 2024. "Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    4. Bailey B. Banach & Sergei Pletnev & Adam S. Olia & Kai Xu & Baoshan Zhang & Reda Rawi & Tatsiana Bylund & Nicole A. Doria-Rose & Thuy Duong Nguyen & Ahmed S. Fahad & Myungjin Lee & Bob C. Lin & Tracy , 2023. "Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    5. Ignacio Fernández & Lasse Toftdal Dynesen & Youna Coquin & Riccardo Pederzoli & Delphine Brun & Ahmed Haouz & Antoine Gessain & Félix A. Rey & Florence Buseyne & Marija Backovic, 2023. "The crystal structure of a simian Foamy Virus receptor binding domain provides clues about entry into host cells," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    6. Mathilde Foglierini & Pauline Nortier & Rachel Schelling & Rahel R. Winiger & Philippe Jacquet & Sijy O’Dell & Davide Demurtas & Maxmillian Mpina & Omar Lweno & Yannick D. Muller & Constantinos Petrov, 2024. "RAIN: machine learning-based identification for HIV-1 bNAbs," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    7. Jun Niu & Qi Wang & Wenwen Zhao & Bing Meng & Youwei Xu & Xianfang Zhang & Yi Feng & Qilian Qi & Yanling Hao & Xuan Zhang & Ying Liu & Jiangchao Xiang & Yiming Shao & Bei Yang, 2023. "Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    8. Yi-Nan Zhang & Jennifer Paynter & Aleksandar Antanasijevic & Joel D. Allen & Mor Eldad & Yi-Zong Lee & Jeffrey Copps & Maddy L. Newby & Linling He & Deborah Chavez & Pat Frost & Anna Goodroe & John Du, 2023. "Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates," Nature Communications, Nature, vol. 14(1), pages 1-29, December.
    9. Jeffy G. Mattathil & Asisa Volz & Olusegun O. Onabajo & Sean Maynard & Sandra L. Bixler & Xiaoying X. Shen & Diego Vargas-Inchaustegui & Marjorie Robert-Guroff & Celia Lebranche & Georgia Tomaras & Da, 2023. "Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    10. Annemart Koornneef & Kanika Vanshylla & Gijs Hardenberg & Lucy Rutten & Nika M. Strokappe & Jeroen Tolboom & Jessica Vreugdenhil & Karin Feddes-de Boer & Aditya Perkasa & Sven Blokland & Judith A. Bur, 2024. "CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    11. Joana Dias & Giulia Fabozzi & Slim Fourati & Xuejun Chen & Cuiping Liu & David R. Ambrozak & Amy Ransier & Farida Laboune & Jianfei Hu & Wei Shi & Kylie March & Anna A. Maximova & Stephen D. Schmidt &, 2024. "Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    12. Christoph Kreer & Cosimo Lupo & Meryem S. Ercanoglu & Lutz Gieselmann & Natanael Spisak & Jan Grossbach & Maike Schlotz & Philipp Schommers & Henning Gruell & Leona Dold & Andreas Beyer & Armita Nourm, 2023. "Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    13. Li Chen & Mengmeng Sun & Huajun Zhang & Xinghai Zhang & Yanfeng Yao & Ming Li & Kangyin Li & Pengfei Fan & Haiwei Zhang & Ye Qin & Zhe Zhang & Entao Li & Zhen Chen & Wuxiang Guan & Shanshan Li & Chang, 2024. "Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains," Nature Communications, Nature, vol. 15(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28450-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.